Endocrinology

Autonomics and Hypertension

Questions discussed in this category

How do you recommend mitigating the risks of using beta blocker and clonidine therapy in combination for management of hypertension?

2 Answers available

Is azilsartan superior to other angiotension receptor blockers in regard to cardiorenal outcome data?

1 Answer available

Is it a good practice to prescribe clonidine to take as needed for occasional severe blood pressure elevations?

2 Answers available

How do the results of the ESPRIT trial, which evaluated the impact of an SBP target of <120 mmHg on preventing major cardiovascular events, influence your blood pressure management goals for hypertensive patients with diabetes or a history of stroke?

ESPRIT Trial

1 Answer available

Papers discussed in this category

Lancet (London, England), 2024 Jun 27

Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.

N Engl J Med, 2015 Nov 09

A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Hypertension (Dallas, Tex. : 1979), 2022 Mar 09

Impact of Antihypertensive Drug Class on Outcomes in SPRINT.

Related Topics in Endocrinology